Designing Better Molecules
Traditional drug discovery relies on finding a needle in a haystack—screening millions of existing compounds to see if one sticks. Directed evolution flips this script. By using algorithms to simulate how proteins interact, we can "evolve" new molecules in the computer and then synthesize them in the lab. For DYRK1A, this means creating highly specific kinase inhibitors (or activators) that can cross the blood-brain barrier and modulate the enzyme's activity without touching its cousins in the kinase family, reducing side effects.
RNA Therapeutics
For DDX3X, where the problem is often a non-functional protein, small molecules might not be enough. Here, RNA therapeutics offer a promising avenue. Antisense oligonucleotides (ASOs) can be designed to skip over mutation-containing exons or to boost the expression of the healthy copy of the gene (in females). In more advanced approaches, we are exploring mRNA replacement therapy—delivering the correct blueprint for the DDX3X protein directly to neurons via lipid nanoparticles.
Correcting the Circuitry
Beyond fixing the gene, we can target the downstream consequences. Since we know that Wnt signaling is impaired in DDX3X syndrome, can we use existing Wnt agonists to rescue the migration defects? Early data from organoids suggests yes. Similarly, for DYRK1A, drugs that enhance GABAergic signaling could theoretically rebalance the E/I ratio, calming the "noisy" brain and opening a window for speech therapy to be effective.
The Future of Trials
These molecular interventions allow us to envision a new kind of clinical trial. Instead of grouping all "autistic" children together, we would recruit specific cohorts based on their genetic profile—a "basket trial" design. A child with a DYRK1A mutation would receive a DYRK1A modulator; a child with a DDX3X mutation would receive an RNA therapy. This precision approach is the only way to tackle the heterogeneity of nonverbal autism.
Excerpt from: Sculpting Silence: Targeting DDX3X and DYRK1A in Nonverbal Autism by Peter De Ceuster
© All rights reserved. Do not distribute.